Expertise in
5
conditions

Thomas M. Decker

Ravensburg, BW, DE 
Expertise in
5
conditions
Ravensburg, BW, DE 

Overview

Thomas Decker practices practicing medicine in Ravensburg, Germany.

Mr. Decker is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Breast Cancer, Colorectal Cancer, Listeriosis, and PIK3CA-Related Overgrowth Spectrum.

He is actively involved in clinical research, co-authoring 219 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Ravensburg, BW, Germany
Other Locations
Muenster, NW, Germany
Berlin, BE, Germany
Chair For Wind Power Drives, Campus Boulevard 61, Aachen, NW 52074, Germany
Landshut, BY 84028, Germany
Neubrandenburg, MV, Germany
Kronach, BY, Germany
Munich, BY, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Rucaparib MAintenance After Bevacizumab Maintenance Following Carboplatin Based First Line Chemotherapy in Ovarian Cancer Patients
Rucaparib MAintenance After Bevacizumab Maintenance Following Carboplatin Based First Line Chemotherapy in Ovarian Cancer Patients
Enrollment Status: Completed
Publish Date: November 15, 2024
Intervention Type: Drug
Study Drug: Rucaparib
Study Phase: Phase 3
An Open Label, randomIzed Controlled Prospective Multicenter Two Arm Phase IV Trial to Determine Patient Preference for Everolimus in Combination With Exemestane or Capecitabine in Combination With Bevacizumab for Advanced (Inoperable or Metastatic) HER2-negative Hormone Receptor Positive Breast Cancer
An Open Label, randomIzed Controlled Prospective Multicenter Two Arm Phase IV Trial to Determine Patient Preference for Everolimus in Combination With Exemestane or Capecitabine in Combination With Bevacizumab for Advanced (Inoperable or Metastatic) HER2-negative Hormone Receptor Positive Breast Cancer
Enrollment Status: Completed
Publish Date: November 13, 2017
Intervention Type: Other, Drug
Study Phase: Phase 4
View 1 Less Clinical Trial

219 Total Publications

Guidance for laboratory implementation, governance and continuous assurance of artificial intelligence in histopathology.
Guidance for laboratory implementation, governance and continuous assurance of artificial intelligence in histopathology.
Journal: Virchows Archiv : an international journal of pathology
Published: August 03, 2026

Frequently Asked Questions about Thomas M. Decker

Is Thomas M. Decker a top-rated expert for Breast Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Thomas M. Decker is classified as an Elite expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Thomas M. Decker participate in research or clinical trials?

Yes. Thomas M. Decker has published 219 articles and abstracts on conditions like Breast Cancer. You can view a list of Thomas M. Decker's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Decker's expertise for a condition
ConditionClose
View All 26 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile